MarketPeel
Insider Trading Intelligence
PT

Peter A. Thompson

SPRY
DIRECTOR · ARS PHARMACEUTICALS, INC. · CIK 0001357522
FILING MIX · LIFETIME57%/43%
BUYS
65
SELLS
50
TOTAL VALUE
$159.95M
COMPANIES
6
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
2,646,087
AVG SELL PX
$17.54
TRADE KIND
SHOWING 115 / 115
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
17 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Peter A. Thompson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d17+47.06%-0.88%+1.00%-1.89%-0.16%
14d17+64.71%-6.16%+1.03%-7.18%-7.75%
30d17+70.59%-12.93%-0.47%-12.46%-12.25%
60d17+76.47%-10.14%-0.09%-10.05%-10.27%
90d17+82.35%-10.19%+1.29%-11.47%-16.73%
180d17+82.35%-12.72%+1.98%-16.15%-22.65%
1y17(7 pending)+70.00%+7.65%+2.58%+5.07%-17.51%
2y17(8 pending)+77.78%-19.90%+14.28%-34.18%-52.42%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SPRY · 30,000 shares · as of Jun 24, 2026
02,004,7974,009,5946,014,3908,019,187202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 65 buys / 50 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
115,844$45.50$5.27M2,555,877Jun 30, 2026Jul 2, 2026View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 24, 2026Jun 26, 2026View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,34017,340Jun 17, 2026Jun 18, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 11, 2026Jun 15, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,37716,377Jun 5, 2026Jun 16, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
101$44.49$4.5K2,671,721May 27, 2026May 29, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
184,639$46.22$8.53M2,671,822May 11, 2026May 11, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
59,767$44.58$2.66M2,856,461May 8, 2026May 11, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
48,546$44.61$2.17M2,916,228May 7, 2026May 11, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,948$44.52$131.2K2,964,774Apr 18, 2026Apr 21, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
52,397$44.68$2.34M2,967,722Apr 17, 2026Apr 21, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
226,906$45.34$10.29M3,020,119Apr 16, 2026Apr 16, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
235,863$44.64$10.53M3,247,025Apr 15, 2026Apr 16, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
47,814$44.51$2.13M3,482,888Apr 14, 2026Apr 16, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
29,063$44.58$1.30M3,530,702Feb 3, 2026Feb 4, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,890$44.57$84.2K3,559,765Feb 2, 2026Feb 4, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$0.97$14.5K165,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$3.27$49.0K105,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$2.00$30.0K90,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
30,000$15.00$450.0K30,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
SALE
30,0000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$2.12$31.8K210,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
SALE
15,0000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$2.60$39.0K135,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$2.49$37.4K180,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$1.64$24.6K195,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$3.61$54.1K75,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$9.70$145.5K45,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$2.74$41.1K120,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$0.99$14.8K150,000Jan 28, 2026Jan 30, 2026View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
15,000$12.50$187.5K60,000Jan 28, 2026Jan 30, 2026View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
33,356$44.55$1.49M3,561,655Dec 24, 2025Dec 29, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
875$44.49$38.9K3,595,011Dec 19, 2025Dec 19, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$44.49$4.4K3,595,886Dec 18, 2025Dec 19, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
900$44.50$40.0K3,595,986Dec 17, 2025Dec 19, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,600$44.49$71.2K3,596,886Nov 26, 2025Nov 26, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
11,890$44.60$530.3K3,598,486Nov 25, 2025Nov 26, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
94,583$44.54$4.21M3,610,376Nov 24, 2025Nov 26, 2025View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
1,397,684$3.50$4.89M8,341,338Jun 27, 2025Jul 1, 2025View →
CRVS
CORVUS PHARMACEUTICALS, INC.
SALE
1,397,6840Jun 27, 2025Jul 1, 2025View →
CRVS
CORVUS PHARMACEUTICALS, INC.
SALE
1,176,332$4.16$4.89M7,165,006Jun 27, 2025Jul 1, 2025View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 25, 2025Jun 27, 2025View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 16, 2025Jun 18, 2025View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 12, 2025Jun 16, 2025View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,95919,959Jun 12, 2025Jun 16, 2025View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
124,193$20.13$2.50M443,792Apr 3, 2025Apr 4, 2025View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
372,578$20.13$7.50M14,809,075Apr 3, 2025Apr 4, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2,048,7600Feb 10, 2025Feb 10, 2025View →
SION
SIONNA THERAPEUTICS, INC.
SALE
2,560,9510Feb 10, 2025Feb 10, 2025View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
550,000$18.00$9.90M3,704,959Feb 10, 2025Feb 10, 2025View →
SION
SIONNA THERAPEUTICS, INC.
PURCHASE
3,154,9593,154,959Feb 10, 2025Feb 10, 2025View →
SPRY
ARS PHARMACEUTICALS, INC.
SALE
83,695$13.00$1.09M0Aug 26, 2024Aug 28, 2024View →
SPRY
ARS PHARMACEUTICALS, INC.
SALE
69,500$13.03$905.6K83,695Aug 23, 2024Aug 23, 2024View →
SPRY
ARS PHARMACEUTICALS, INC.
SALE
391,482$12.94$5.07M153,195Aug 22, 2024Aug 23, 2024View →
SPRY
ARS PHARMACEUTICALS, INC.
SALE
13,300$14.61$194.3K544,677Aug 21, 2024Aug 23, 2024View →
SPRY
ARS PHARMACEUTICALS, INC.
SALE
394,400$13.52$5.33M557,977Aug 21, 2024Aug 23, 2024View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 20, 2024Jun 24, 2024View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 13, 2024Jun 17, 2024View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,59420,594Jun 10, 2024Jun 12, 2024View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
1,397,6841,397,684May 6, 2024May 8, 2024View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
1,444,085$1.73$2.50M1,444,085May 6, 2024May 8, 2024View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
454,545$11.00$5.00M14,436,497Jan 23, 2024Jan 25, 2024View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Dec 6, 2023Dec 8, 2023View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASE
500,000$6.20$3.10M8,019,187Aug 29, 2023Aug 31, 2023View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 27, 2023Jun 28, 2023View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 15, 2023Jun 20, 2023View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,12322,123Jun 12, 2023Jun 14, 2023View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
484,496$10.32$5.00M13,981,952Sep 16, 2022Sep 16, 2022View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Aug 11, 2022Aug 15, 2022View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,08742,087Jun 24, 2022Jun 28, 2022View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 15, 2022Jun 17, 2022View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,50012,500Jun 14, 2022Jun 16, 2022View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,33316,333Jun 2, 2022Jun 9, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
138,000$7.21$995.0K13,497,456May 18, 2022May 20, 2022View →
JANX
JANUX THERAPEUTICS, INC.
SALE
36,700$20.30$745.0K2,258,566Dec 29, 2021Dec 30, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
3,700$20.30$75.1K231,098Dec 29, 2021Dec 30, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
108,300$19.00$2.06M2,295,266Dec 21, 2021Dec 23, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
11,100$19.00$210.9K234,798Dec 21, 2021Dec 23, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
36,500$19.07$696.1K245,898Dec 16, 2021Dec 17, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
356,800$19.07$6.80M2,403,566Dec 16, 2021Dec 17, 2021View →
CRVS
CORVUS PHARMACEUTICALS, INC.
SALE
1,109,644$6.09$6.76M6,943,654Sep 20, 2021Sep 22, 2021View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Sep 9, 2021Sep 13, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
823,7422,172,163Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
128,6090Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
1,052,6320Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
1,348,4211,348,421Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
SALE
643,0460Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
117,650$17.00$2.00M282,398Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
588,203$17.00$10.00M2,760,366Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
164,748164,748Jun 15, 2021Jun 16, 2021View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 15, 2021Jun 16, 2021View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 10, 2021Jun 14, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
1,668,3500Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
8,187,1000Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
12,730,03613,046,956Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
272,7240Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
1,572,9600Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
1,301,6260Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
312,500$16.00$5.00M13,359,456Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
46,875$16.00$750.0K319,599Mar 30, 2021Mar 31, 2021View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
272,724272,724Mar 30, 2021Mar 31, 2021View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASE
1,285,714$3.50$4.50M8,053,298Feb 17, 2021Feb 19, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,076,8915,576,967Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
114,039114,039Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
380,1336,475,291Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
4,025,0764,500,076Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
518,1916,095,158Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
4,025,0760Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,076,8910Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
518,1910Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
114,0390Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
380,1330Sep 29, 2020Sep 29, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
475,000$18.00$8.55M475,000Sep 25, 2020Sep 29, 2020View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 9, 2020Jun 12, 2020View →
CRVS
CORVUS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Mar 19, 2020Mar 20, 2020View →
Other insiders · SPRY
Loading peer insiders…
About this filer
CIK 0001357522
ROLE
Director
PRIMARY
SPRY
COMPANIES
6
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001357522DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback